Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.
Identifying genuine bargains from value traps is something many investors struggle with, which is why we started StockStory - to help you find the best companies. Keeping that in mind, here is one value stock trading at a big discount to its intrinsic value and two climbing an uphill battle.
Two Value Stocks to Sell:
Campbell's (CPB)
Forward P/E Ratio: 10.5x
With its iconic canned soup as its cornerstone product, Campbell's (NASDAQ: CPB) is a packaged food company with an illustrious portfolio of brands.
Why Do We Steer Clear of CPB?
- Declining unit sales over the past two years imply it may need to invest in product improvements to get back on track
- Forecasted revenue decline of 1.1% for the upcoming 12 months implies demand will fall off a cliff
- Costs have risen faster than its revenue over the last year, causing its operating margin to decline by 3.6 percentage points
At $32.17 per share, Campbell's trades at 10.5x forward P/E. Check out our free in-depth research report to learn more about why CPB doesn’t pass our bar.
Avis Budget Group (CAR)
Forward P/E Ratio: 11.3x
The parent company of brands such as Zipcar and Budget Truck Rental, Avis (NASDAQ: CAR) is a provider of car rental and mobility solutions.
Why Do We Think CAR Will Underperform?
- Demand for its offerings was relatively low as its number of available rental days - car rental has underwhelmed
- Eroding returns on capital suggest its historical profit centers are aging
- Limited cash reserves may force the company to seek unfavorable financing terms that could dilute shareholders
Avis Budget Group is trading at $154.30 per share, or 11.3x forward P/E. Read our free research report to see why you should think twice about including CAR in your portfolio.
One Value Stock to Watch:
Tenet Healthcare (THC)
Forward P/E Ratio: 14x
With a network spanning nine states and serving primarily urban and suburban communities, Tenet Healthcare (NYSE: THC) operates a nationwide network of hospitals, ambulatory surgery centers, and outpatient facilities providing acute care and specialty healthcare services.
Why Does THC Stand Out?
- Share repurchases have amplified shareholder returns as its annual earnings per share growth of 29.1% exceeded its revenue gains over the last five years
- Industry-leading 21.3% return on capital demonstrates management’s skill in finding high-return investments, and its returns are climbing as it finds even more attractive growth opportunities
- Returns on capital are climbing as management makes more lucrative bets
Tenet Healthcare’s stock price of $181.95 implies a valuation ratio of 14x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.
Stocks We Like Even More
Trump’s April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.
Take advantage of the rebound by checking out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
